Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary
D

Datopotamab Deruxtecan

Availability of ACE Drug Guidance

Yes

Biologics Drug Information Overview

Yes

Subsidy Information and Financing Scheme

No

Active ingredient: Datopotamab Deruxtecan

General information

Subsidy Information and Financing Scheme

Not Applicable

Drug Guidance for Subsidy

16/09/2025 Datopotamab deruxtecan for previously treated unresectable or metastatic HR-positive, HER2-negative breast cancer

[NR] The Ministry of Health’s Drug Advisory Committee has not recommended datopotamab deruxtecan (Dato-DXd) for inclusion on the MOH List of Subsidised Drugs for treating patients with unresectable or metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer who have received prior endocrine-based therapy and chemotherapy for unresectable or metastatic disease. The decision was based on the unfavourable clinical and cost effectiveness of Dato-DXd compared with chemotherapy, at the price proposed by the company.

Clinical indication, subsidy class and MediShield Life claim limit for datopotamab deruxtecan are provided in the Annex.

View legend

List of monographs containing this active ingredient

Datopotamab Deruxtecan [Datroway]

Back to top